Article Details
Retrieved on: 2022-08-08 16:15:57
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Global Therapeutics makes Oxybryta tablets for treating sickle cell disease. The latest deal follows Pfizer's $11.6 billion acquisition of Biohaven, ...
Article found on: www.newscenter1.tv
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here